These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20847682)

  • 1. The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus.
    Gumus K; Gire A; Pflugfelder SC
    Cornea; 2010 Dec; 29(12):1465-8. PubMed ID: 20847682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma.
    Grover S; Jacobs DS; Colby KA
    Cornea; 2010 Apr; 29(4):459-61. PubMed ID: 20164756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy.
    Pavan-Langston D; Dohlman CH
    Ophthalmology; 2008 Feb; 115(2 Suppl):S21-3. PubMed ID: 18243928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binocular visual function in patients with Boston type I keratoprostheses.
    Pineles SL; Ela-Dalman N; Rosenbaum AL; Aldave AJ; Velez FG
    Cornea; 2010 Dec; 29(12):1397-400. PubMed ID: 20847681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefits of the Boston Ocular Surface Prosthesis.
    Stason WB; Razavi M; Jacobs DS; Shepard DS; Suaya JA; Johns L; Rosenthal P
    Am J Ophthalmol; 2010 Jan; 149(1):54-61. PubMed ID: 19878920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of photorefractive keratectomy in a patient with a corneal scar secondary to herpes zoster ophthalmicus.
    Kaufman SC
    Ophthalmology; 2008 Feb; 115(2 Suppl):S33-4. PubMed ID: 18243931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
    Ling JD; Gire A; Pflugfelder SC
    Am J Ophthalmol; 2013 Apr; 155(4):615-619, 619.e1-2. PubMed ID: 23218704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of herpes zoster ophthalmicus.
    Shaikh S; Ta CN
    Am Fam Physician; 2002 Nov; 66(9):1723-30. PubMed ID: 12449270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial cornea: surgical use of Boston keratoprosthesis.
    John T
    Ann Ophthalmol (Skokie); 2008; 40(1):2-7. PubMed ID: 18556973
    [No Abstract]   [Full Text] [Related]  

  • 12. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience.
    Ament JD; Tilahun Y; Mudawi E; Pineda R
    Arch Ophthalmol; 2010 Jun; 128(6):795-7. PubMed ID: 20547962
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface.
    Lim P; Ridges R; Jacobs DS; Rosenthal P
    Am J Ophthalmol; 2013 Dec; 156(6):1095-101. PubMed ID: 24075432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boston type I keratoprosthesis assisted with intraprosthetic amniotic membrane (AmniotiKPro sandwich technique).
    Navas A; Hernandez-Camarena JC; Serna-Ojeda JC; Ramirez-Miranda A; Graue-Hernández EO
    Acta Ophthalmol; 2015 Feb; 93(1):e87-8. PubMed ID: 24797302
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetrating keratoplasty for corneal scarring due to herpes zoster ophthalmicus.
    Soong HK; Schwartz AE; Meyer RF; Sugar A
    Br J Ophthalmol; 1989 Jan; 73(1):19-21. PubMed ID: 2645929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation.
    Tsubota K; Satake Y; Kaido M; Shinozaki N; Shimmura S; Bissen-Miyajima H; Shimazaki J
    N Engl J Med; 1999 Jun; 340(22):1697-703. PubMed ID: 10352161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracorneal ring segment implantation in corneas with post-laser in situ keratomileusis keratectasia.
    Piñero DP; Alio JL; Uceda-Montanes A; El Kady B; Pascual I
    Ophthalmology; 2009 Sep; 116(9):1665-74. PubMed ID: 19643485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.
    Dunn SP; Heidemann DG; Chow CY; Crockford D; Turjman N; Angel J; Allan CB; Sosne G
    Arch Ophthalmol; 2010 May; 128(5):636-8. PubMed ID: 20457990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.